1. A. Consumable hemp products must bear labeling that includes a scannable bar code, QR code, or a web address linked to a document or website containing the certificate of analysis for that product.
2. B. The certificate of analysis must be from a laboratory that is accredited by the Louisiana Department of Health, Office of Public Health (LDH/OPH). Accreditation will be demonstrated by the availability of a current audit from a third-party entity indicating that the laboratory meets the criteria specified in Standard 17025 of the accrediting body.

3. C. The certificate of analysis must include, at a minimum, the following information:

   1. 1. the batch number of the product;
   2. 2. the date the batch was received by the laboratory;
   3. 3. the date the testing was completed;
   4. 4. the laboratory methodology used for each analysis referenced in the report;
   5. 5. a cannabinoid profile for the finished product listing all major cannabinoid constituents by percentage of dry weight;
   6. 6. serving size for the product, total THC (as defined in R.S. 3:1481) per serving, number of servings per package, and total THC per package (expressed in terms of milligrams per gram);

   7. 7. the amount of any detected residual solvent in the product in the product in parts per million, except that this analyte will not be required for floral hemp material; detections may not meet or exceed the following amounts:

      1. a. butanes—800 ppm;
      2. b. heptanes—500 ppm;
      3. c. benzene—1 ppm;
      4. d. toluene—1 ppm;
      5. e. hexanes—10 ppm;
      6. f. xylenes—1 ppm;
      7. g. ethanol—5,000 ppm; this ethanol limit shall not apply to consumable hemp products designed and intended solely for topical use;
   8. 8. the amount of any detected pesticide residues in the product in parts per million; any detection above the limit of quantitation for a category I pesticide (see Table 1 of this Section) is defined as an exceedance and a basis for rejection of the product by the department; category II pesticides have maximum contaminant levels as defined in Table 1;
   9. 9. the amount of any microbiological contaminants in the product in appropriate units; total yeast/mold may not meet or exceed 10,000 colony-forming units per gram and total pathogenic Escherichia coli bacteria or Salmonella spp. may not meet or exceed 1 colony-forming unit per gram;

   10. 10. the amount of any detected heavy metal traces in the product in parts per million; detections may not meet or exceed the following amounts:

       1. a. arsenic (As)—10 ppm;
       2. b. cadmium (Cd)—4.1 ppm;
       3. c. lead (Pb)—10 ppm;
       4. d. mercury (Hg)—2 ppm;
   11. 11. a cannabinoid profile for the “active ingredient” (cannabinoid-containing distillate or isolate used in formulating the finished product) listing all major cannabinoid constituents by percentage of dry weight.

4. D. Table 1: Category I and II Pesticides

   Name	Maximum Contaminant Level (MCL) in ppm
   Category I (includes aldicarb, carbofuran, chlorpyrifos, coumaphos, daminozide, dichloryos, dimethoate, ethoprop(hos), etofenprox, fenoxycarb, imazalil, methocarb, methyl parathion, meyinphos, paclobutrazol, propoxur, spiroxamine, and thiacloprid)	0
   Category II
   Abamectin	0.3
   Acephate	5
   Acetamiprid	5
   Acequinocyl	4
   Azoxystrobin	40
   Bifenazate	5
   Bifenthrin	0.5
   Boscalid	10
   Captan	5
   Carbaryl	0.5
   Chlorantraniliprole	40
   Clofentezine	0.5
   Cyfluthrin	1
   Cypermethrin	1
   Diazinon	0.2
   Dimethomorph	20
   Etoxazole	1.5
   Fenhexamid	10
   Fenpyroximate	2
   Flonicamid	2
   Hexythiazox	2
   Fludioxionil	30
   Imidacloprid	3
   Kresoxim-methyl	1
   Malathion	5
   Metalaxyl	15
   Methomyl	0.1
   Myclobutanil	9
   Naled	0.5
   Oxamyl	0.2
   Pentachloronitrobenzene	0.2
   Permethrin	20
   Phosmet	0.2
   Piperonylbutoxide	8
   Prallethrin	0.4
   Propiconazole	20
   Pyrethrins	1
   Pyradiben	3
   Spinetoram	3
   Spinosad	3
   Spiromesifen	12
   Spirotetramat	13
   Tebuconazole	2
   Thiamethoxam	4.5
   Trifloxystrobin	30

Authority Note

AUTHORITY NOTE: Promulgated in accordance with R.S. 40:4(A)(13), R.S. 3:1483(L) and R.S. 40:604.

Historical Note

HISTORICAL NOTE: Promulgated by the Department of Health, Office of Public Health, LR 46:359 (March 2020), amended LR 47:480 (April 2021), LR 48:1291 (May 2022), amended LR 48:2982 (December 2022), amended LR 50:395 (March 2024), LR 52:57 (January 2026).